IOL Chemicals and Pharmaceuticals Limited - Asset Resilience Ratio

Latest as of March 2026: 0.14%

IOL Chemicals and Pharmaceuticals Limited (IOLCP) has an Asset Resilience Ratio of 0.14% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See IOLCP current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Rs35.10 Million
≈ $379.59K USD Cash + Short-term Investments

Total Assets

Rs25.87 Billion
≈ $279.77 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2005–2026)

This chart shows how IOL Chemicals and Pharmaceuticals Limited's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see IOL Chemicals and Pharmaceuticals Limite balance sheet assets.

Liquid Assets Composition Over Time

This chart breaks down IOL Chemicals and Pharmaceuticals Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore how much of IOL Chemicals and Pharmaceuticals Limite's assets are long-term investments to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Rs0.00 0%
Short-term Investments Rs35.10 Million 0.14%
Total Liquid Assets Rs35.10 Million 0.14%

Asset Resilience Insights

  • Limited Liquidity: IOL Chemicals and Pharmaceuticals Limited maintains only 0.14% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

IOL Chemicals and Pharmaceuticals Limited Industry Peers by Asset Resilience Ratio

Compare IOL Chemicals and Pharmaceuticals Limited's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
Drug Manufacturers - Specialty & Generic 0.20%
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
Drug Manufacturers - Specialty & Generic 4.94%
Beijing Tongrentang Co Ltd
SHG:600085
Drug Manufacturers - Specialty & Generic 0.50%
Takeda Pharmaceutical Company Limited
F:TKDA
Drug Manufacturers - Specialty & Generic 0.69%
Changchun High & New Technology Industries Group Inc
SHE:000661
Drug Manufacturers - Specialty & Generic 5.50%
Neuland Laboratories Limited
NSE:NEULANDLAB
Drug Manufacturers - Specialty & Generic 9.65%
China Resources Double-Crane Pharmaceutical Co Ltd
SHG:600062
Drug Manufacturers - Specialty & Generic 1.18%
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
Drug Manufacturers - Specialty & Generic 0.01%

Annual Asset Resilience Ratio for IOL Chemicals and Pharmaceuticals Limited (2005–2026)

The table below shows the annual Asset Resilience Ratio data for IOL Chemicals and Pharmaceuticals Limited.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2026-03-31 0.14% Rs35.10 Million
≈ $379.59K
Rs25.87 Billion
≈ $279.77 Million
-5.37pp
2025-03-31 5.50% Rs1.31 Billion
≈ $14.18 Million
Rs23.82 Billion
≈ $257.61 Million
-0.50pp
2024-03-31 6.01% Rs1.35 Billion
≈ $14.58 Million
Rs22.44 Billion
≈ $242.72 Million
+4.93pp
2023-03-31 1.08% Rs217.50 Million
≈ $2.35 Million
Rs20.22 Billion
≈ $218.69 Million
-4.86pp
2022-03-31 5.94% Rs1.17 Billion
≈ $12.60 Million
Rs19.62 Billion
≈ $212.22 Million
-13.89pp
2021-03-31 19.83% Rs3.19 Billion
≈ $34.53 Million
Rs16.10 Billion
≈ $174.13 Million
+11.05pp
2020-03-31 8.78% Rs1.03 Billion
≈ $11.11 Million
Rs11.70 Billion
≈ $126.51 Million
+8.77pp
2019-03-31 0.01% Rs600.00K
≈ $6.49K
Rs9.42 Billion
≈ $101.86 Million
-2.03pp
2018-03-31 2.04% Rs173.80 Million
≈ $1.88 Million
Rs8.52 Billion
≈ $92.15 Million
+0.03pp
2017-03-31 2.01% Rs164.40 Million
≈ $1.78 Million
Rs8.17 Billion
≈ $88.41 Million
+2.01pp
2016-03-31 0.01% Rs457.23K
≈ $4.94K
Rs7.76 Billion
≈ $83.91 Million
+0.00pp
2015-03-31 0.00% Rs99.90K
≈ $1.08K
Rs7.02 Billion
≈ $75.88 Million
-1.20pp
2012-03-31 1.20% Rs82.56 Million
≈ $892.83K
Rs6.87 Billion
≈ $74.29 Million
-1.02pp
2006-03-31 2.22% Rs21.03 Million
≈ $227.45K
Rs946.52 Million
≈ $10.24 Million
+0.80pp
2005-03-31 1.42% Rs8.55 Million
≈ $92.50K
Rs600.82 Million
≈ $6.50 Million
--
pp = percentage points

About IOL Chemicals and Pharmaceuticals Limited

NSE:IOLCP India Drug Manufacturers - Specialty & Generic
Market Cap
$569.87 Million
Rs52.69 Billion INR
Market Cap Rank
#11591 Global
#573 in India
Share Price
Rs179.52
Change (1 day)
-7.61%
52-Week Range
Rs68.21 - Rs213.04
All Time High
Rs840.03
About

IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company operates through, Chemical and Pharmaceutical segments. The Chemical segment offers ethyl acetate, iso butyl benzene, acetyl chloride, mono chloro acetic acid, and acetic anhydride to food processing, flexible packaging, pharmaceuticals, textiles, ink, pa… Read more